Needham raised the firm’s price target on AdTheorent to $3.75 from $3 and keeps a Buy rating on the shares. The company reported strong Q4 results showing “accelerating growth”, the analyst tells investors in a research note. Needham adds that it sees an acceleration in FY24 revenue growth to 12%, driven by AdTheorent’s health product, with revenue upside from connected TV, travel. and financial services.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ADTH:
- AdTheorent Holding Company, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results
- AdTheorent to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on March 12, 2024
- AdTheorent price target raised to $3 from $2 at Needham
- AdTheorent, Adelaide partner for campaign optimization, measurement